Skip to Main Content

Author Details

Anuradha Gopalan
Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
2000
104
41
PMIDPaper TitleJournal TitlePublished Year
36115772Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer.Eur Urol2023
37582240Randomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer.J Clin Oncol2023
37018402ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer.Sci Adv2023
37243318Ganglioneuroblastoma intermixed: Clinicopathological implications of diagnosis at presentation and genomic correlations.Pediatr Blood Cancer2023
35946087Reporting Trends, Practices, and Resource Utilization in Neuroendocrine Tumors of the Prostate Gland: A Survey among Thirty-Nine Genitourinary Pathologists.Int J Surg Pathol2023
34161656Clinical utility of subclassifying positive surgical margins at radical prostatectomy.BJU Int2022
35617398Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets.Science2022
35676169Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy.Clin Genitourin Cancer2022
35731998Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype.JCO Precis Oncol2022
35758203Neuroendocrine differentiation in the setting of prostatic carcinoma: contemporary assessment of a consecutive series.Histopathology2022
37145713Impact of Zone of Origin in Anterior Dominant Prostate Cancer: Long-Term Biochemical Recurrence-Free Survival in an Anatomically Well-Characterized Cohort.Urol Pract2022
36564410Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.Nat Commun2022
36323682FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.Nat Commun2022
35981096Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signaling.Science2022
34549366TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas.Endocr Pathol2022
34802033Prognostic and therapeutic significance of COP9 signalosome subunit CSN5 in prostate cancer.Oncogene2022
32879414Adverse histology, homozygous loss of CDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinoma.Mod Pathol2021
35071713<i>CD274</i> (<i>PD-L1</i>) Copy Number Changes (Gain) &amp; Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary Tract.Bladder Cancer2021
33285287A Pan-Cancer Study of Somatic TERT Promoter Mutations and Amplification in 30,773 Tumors Profiled by Clinical Genomic Sequencing.J Mol Diagn2021
31584841Practice Patterns in Reporting Tertiary Grades at Radical Prostatectomy: Survey of a Large Group of Experienced Urologic Pathologists.Arch Pathol Lab Med2020
31876541Morphologic and Immunohistochemical Assessment of CDH1 Loss of Function Alterations in Prostatic Adenocarcinoma.Am J Surg Pathol2020
31644329PD-1 Blockade in Advanced Adrenocortical Carcinoma.J Clin Oncol2020
32015092Oncogenic ERG Represses PI3K Signaling through Downregulation of IRS2.Cancer Res2020
32094488Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer.Prostate Cancer Prostatic Dis2020
32914407Predicting malignancy in patients with adrenal tumors using <sup>18</sup> F-FDG-PET/CT SUVmax.J Surg Oncol2020
32679108Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer.Cancer Cell2020
32820258Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate.Nat Genet2020
32355025Regenerative potential of prostate luminal cells revealed by single-cell analysis.Science2020
32317181Pan-cancer Analysis of CDK12 Alterations Identifies a Subset of Prostate Cancers with Distinct Genomic and Clinical Characteristics.Eur Urol2020
31502941<i>PTEN</i> Loss with <i>ERG</i> Negative Status is Associated with Lethal Disease after Radical Prostatectomy.J Urol2020
30300632Clinical Usefulness of Prostate and Tumor Volume Related Parameters following Radical Prostatectomy for Localized Prostate Cancer.J Urol2019
30076908Clinical Usefulness of Total Length of Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer.J Urol2019
31296553Aberrant Expression of ERG Promotes Resistance to Combined PI3K and AR Pathway Inhibition through Maintenance of AR Target Genes.Mol Cancer Ther2019
31600176TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic Correlations.Am J Surg Pathol2019
31017093Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer.Eur Urol Oncol2019
30838648Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladder.J Pathol2019
30980040Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases.Mod Pathol2019
31061129Genomic correlates of clinical outcome in advanced prostate cancer.Proc Natl Acad Sci U S A2019
31107718In Organ-confined Prostate Cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical Recurrence.Am J Surg Pathol2019
30996253JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management.Mod Pathol2019
31135485PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology: Concordance Among 3 Commonly Used and Commercially Available Antibodies.Am J Surg Pathol2019
30295067Effect of Preanalytic Variables on an Automated PTEN Immunohistochemistry Assay for Prostate Cancer.Arch Pathol Lab Med2019
30622286Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile.Mod Pathol2019
30644358GREB1 amplifies androgen receptor output in human prostate cancer and contributes to antiandrogen resistance.Elife2019
30589920Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade.JAMA Oncol2019
30303819Somatic Mutations of TSC2 or MTOR Characterize a Morphologically Distinct Subset of Sporadic Renal Cell Carcinoma With Eosinophilic and Vacuolated Cytoplasm.Am J Surg Pathol2019
28555354Contiguous gene deletion of chromosome 2p16.3-p21 as a cause of Lynch syndrome.Fam Cancer2018
29878934Comedonecrosis Revisited: Strong Association With Intraductal Carcinoma of the Prostate.Am J Surg Pathol2018
29462091Distinct Genomic Copy Number Alterations Distinguish Mucinous Tubular and Spindle Cell Carcinoma of the Kidney From Papillary Renal Cell Carcinoma With Overlapping Histologic Features.Am J Surg Pathol2018
29601842Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma.Hum Pathol2018
  • 1 - 50 of 104

Recommended Authors

Susan Prendeville
University of Toronto
Career Start Year 2013
Number of shared co-authors 13
Jacqueline Fontugne
Institut Curie, CNRS, PSL Research University
Career Start Year 2013
Number of shared co-authors 27
Steven Hazell
Royal Marsden NHS Foundation Trust
Career Start Year 2011
Number of shared co-authors 11
Kyung Park
New York University Langone Health
Career Start Year 2010
Number of shared co-authors 35
Verena Sailer
Institute for Pathology, University Hospital Schleswig-Holstein
Career Start Year 2007
Number of shared co-authors 34
Fadi Brimo
McGill University Health Centre, McGill University
Career Start Year 2007
Number of shared co-authors 22
Roula Albadine
Centre hospitalier de l'Universite de Montreal
Career Start Year 2006
Number of shared co-authors 14
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 37
Thorsten Schlomm
Charite - University Hospital Berlin
Career Start Year 2004
Number of shared co-authors 16
Huihui Ye
College of Optical Science and Engineering, Zhejiang University
Career Start Year 2004
Number of shared co-authors 27
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 61
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 16
Tarek A Bismar
University of Calgary Cumming School of Medicine, Rockyview General Hospital
Career Start Year 2002
Number of shared co-authors 41
Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2001
Number of shared co-authors 21
Jiaoti Huang
Duke University School of Medicine
Career Start Year 2000
Number of shared co-authors 27
Claudia Hube-Magg
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1997
Number of shared co-authors 2
Andrew J Evans
Princess Margaret Cancer Center, University Health Network.
Career Start Year 1996
Number of shared co-authors 23
Lars Egevad
Karolinska Institute
Career Start Year 1995
Number of shared co-authors 34
David Clouston
Career Start Year 1995
Number of shared co-authors 11
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 31
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Holger Moch
University Hospital Zurich
Career Start Year 1991
Number of shared co-authors 27
Guido Sauter
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1990
Number of shared co-authors 18
Bernd Wullich
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 1989
Number of shared co-authors 2
Peter A Humphrey
Yale University School of Medicine
Career Start Year 1986
Number of shared co-authors 19
Edward C Jones
University of British Columbia
Career Start Year 1985
Number of shared co-authors 8
Dominique Trudel
Institut du cancer de Montreal
Career Start Year 1985
Number of shared co-authors 25
John R Srigley
University of Toronto
Career Start Year 1980
Number of shared co-authors 23
Maria J Merino
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 7
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 21

Collaborators

Victor E Reuter
Memorial Sloan Kettering Cancer Center
Co-authored papers 63
Sahussapont J Sirintrapun
Memorial Sloan Kettering Cancer Center
Co-authored papers 25
Howard I Scher
Memorial Sloan Kettering Cancer Center
Co-authored papers 16
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Co-authored papers 15
Yu Chen
School of Pharmacy, University of Wisconsin-Madison
Co-authored papers 13
Wassim Abida
Memorial Sloan Kettering Cancer Center
Co-authored papers 12
Michael F Berger
Co-authored papers 10
Michael J Morris
Memorial Sloan Kettering Cancer Center
Co-authored papers 9
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
Dana E Rathkopf
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
Philip W Kantoff
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Mark A Rubin
University of Bern
Co-authored papers 6
Andrea Sboner
Institute for Computational Biomedicine
Co-authored papers 6
Rohit Mehra
Michigan Center for Translational Pathology.
Co-authored papers 6
Juan Miguel Mosquera
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 6
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers 6
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 4
Mary-Ellen Taplin
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Co-authored papers 4
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 4
Nicholas D Socci
Co-authored papers 4
Stephen B Solomon
Memorial Sloan-Kettering Cancer Center
Co-authored papers 4
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Co-authored papers 4
Yonghong Xiao
TESARO Inc.
Co-authored papers 3
Jake Vinson
Prostate Cancer Clinical Trials Consortium (PCCTC)
Co-authored papers 3
Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers 3
Elisabeth I Heath
Karmanos Cancer Center, Wayne State University
Co-authored papers 3
Michael F Walsh
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Susana Miranda
The Institute of Cancer Research
Co-authored papers 3
Release 1.2